Changshan Biochemical Pharmaceutical's Unit Gets EU GMP Certificate

MT NewswiresSep 26 02:10 ET

Is Hebei Changshan Biochemical Pharmaceutical (SZSE:300255) Using Too Much Debt?

Simply Wall StSep 23 21:36 ET

Hebei Changshan Biochemical Pharmaceutical (300255.SZ): The production facility of Enoxaparin Sodium Injection has passed the European Union GMP certification for the first time.

GeLonghui September 20th | Hebei Changshan Biochemical Pharmaceutical (300255.SZ) announced that the company recently received a "Drug GMP Certificate" issued by the Republic of Croatia Agency For Medicinal Products And Medical Devices based on the relevant regulations of the European Medicines Agency. Ennogen liver

Gelonghui FinanceSep 20 03:51 ET

Changshan Pharmaceutical: 2024 Semi-Annual Report Summary

SZSIAug 28 12:00 ET · Announcements

Changshan Pharmaceutical: Semi-Annual Report 2024

SZSIAug 28 12:00 ET · Announcements

Hebei Changshan Biochemical Pharmaceutical (300255.SZ) released its semi-annual performance report, with a net loss of 46.9027 million yuan, a year-on-year decrease of 69.91%.

Hebei Changshan Biochemical Pharmaceutical (300255.SZ) released its semi-annual report for 2024, with the company achieving revenue of 5...

Zhitong FinanceAug 28 04:23 ET